Back to search

Article

Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of Multiple Sulfatase Deficiency

2024-03-12

Abstract excerpt

<h4>ABSTRACT</h4> Multiple sulfatase deficiency (MSD) is a severe, lysosomal storage disorder caused by pathogenic variants in the gene SUMF1, encoding the sulfatase modifying factor formylglycine-generating enzyme. Patients with MSD exhibit functional deficiencies in all cellular sulfatases. The inability of sulfatases to break down their substrates leads to progressive and multi-systemic complications in patie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
30a9f5b1-52c7-50c9-b259-d8a221edcea3
DOI
10.1101/2024.03.08.584099
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of Multiple Sulfatase DeficiencyDOI 10.1101/2024.03.08.584099
Select a neighboring publication to make it the new centre.